Chargement en cours...
Naltrexone for treatment of impaired awareness of hypoglycemia in type 1 diabetes: A randomized clinical trial
AIMS: Impaired awareness of hypoglycemia (IAH) is a limiting factor in the treatment of type 1 diabetes (T1D) and is a challenging condition to reverse. The objective of this study was to test the hypothesis that naltrexone therapy in subjects with T1D and IAH will improve counterregulatory hormone...
Enregistré dans:
| Publié dans: | J Diabetes Complications |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4871128/ https://ncbi.nlm.nih.gov/pubmed/26345338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jdiacomp.2015.08.004 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|